Can Creatine Supplementation Improve Body Composition and Physical Function in Rheumatoid Arthritis Patients?
Primary Purpose
Rheumatoid Arthritis
Status
Unknown status
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Creatine
Placebo
Sponsored by
About this trial
This is an interventional treatment trial for Rheumatoid Arthritis focused on measuring Rheumatoid Arthritis, Arthritis, Rheumatology, Creatine
Eligibility Criteria
Inclusion Criteria:
- fulfil the American Rheumatism Association 1987 revised criteria for the diagnosis of RA
- be functional class I or II
- be age 18 years or over
Exclusion Criteria:
- be cognitively impaired; (b) have any other cachectic diseases and any condition preventing safe participation in the study
- have a glomerular filtration rate above 60mL/min/1.73m2, assessed from medical records, and no other evidence of kidney damage
- be taking drugs or other nutritional supplements known to increase muscle mass
- be participating in regular and intense physical training program be pregnant
Sites / Locations
- Bangor University
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
Creatine
Fruit powder drink
Arm Description
Creatine, often found in meat and fish, make up an essential part of the systems that provide energy to the muscles for movement and exercise.
A regular fruit flavoured powder that has no benefits
Outcomes
Primary Outcome Measures
Change in 'Objectively assessed whole body function'
Physical function will be assessed using the following tests:
strength tests of the knee muscles and hand-grip
the Up-and-Go Test (UG) - For the UG, participants are required rise from a seated position on a fixed chair, walk forward to a cone placed 8ft (2.44 m) away, and return to the chair and a seated position.
the sit-to-stand in 30 sec test (SST-30) - For the SST-30 participants will rise from the same seated position as during the UG as many times as possible in 30 s whilst keeping their arms folded across the chest.
50-ft walk test - During the 50-ft walk test, time taken to complete the walk along a straight line marked by cones is recorded
To assess fitness participants will complete the Siconolfi step test.
Secondary Outcome Measures
Change in body composition
Body fat and muscle size (body composition) will be assessed using type of X-ray called 'dual-entry X-ray absorptiometry' (DXA) scans and by looking at body water levels. DXA allows the research team to estimate the amount of lean tissue (muscle) and fat that is in the body. The scan is completely painless.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01767844
Brief Title
Can Creatine Supplementation Improve Body Composition and Physical Function in Rheumatoid Arthritis Patients?
Official Title
Can Creatine Supplementation Improve Body Composition and Physical Function in Rheumatoid Arthritis Patients? A Randomised Controlled Pilot Trial
Study Type
Interventional
2. Study Status
Record Verification Date
December 2014
Overall Recruitment Status
Unknown status
Study Start Date
January 2013 (undefined)
Primary Completion Date
February 2015 (Anticipated)
Study Completion Date
February 2015 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Bangor University
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Rheumatoid arthritis (RA) patients typically experience a significant loss of muscle. In healthy individuals, food supplementation with creatine (Cr) increases muscle size and improves physical function and quality of life. The aim of this study is to investigate whether RA patients may benefit similarly.
50 participants will be given a food supplement to take for 12 weeks; this supplement will either be creatine or a placebo (a regular fruit flavoured powder that has no benefits).
Over 12 weeks, body fat and muscle size (body composition), physical function, and fitness (aerobic capacity of the heart and lungs to transport oxygen to the exercising muscles) will be tested. In addition, quality of life questionnaires will be completed, disease activity will be assessed and blood samples will be taken. Muscle samples (muscle biopsy) will be obtained, from those who volunteer to provide them, at baseline and post-treatment.
Detailed Description
Background and aims
Rheumatoid arthritis (RA) patients typically experience a significant loss of muscle. This reduces their ability to complete daily tasks and increases disability, as well as increasing the risk to infection and other illness.
Exercise is most effective for increasing muscle size and strength, but it is time consuming, expensive and hard work, meaning uptake is poor. So, widely acceptable alternatives are required.
The study aims to test a food supplement called creatine. Creatine, often found in meat and fish, make up an essential part of the systems that provide energy to the muscles for movement and exercise.
The creatine will be provided as a fruit flavoured powder that participants will mix with water and drink, much like a fruit squash. In healthy individuals, food supplementation with creatine (Cr) increases muscle size and improves physical function and quality of life. The aim of this study is to investigate whether RA patients may benefit similarly
Who are the participants?
50 patients with who have stable and controlled RA, are over age 18, with no known kidney problems.
What does the study involve?
50 participants will be given a food supplement to take for 12 weeks; this supplement will either be creatine or a placebo (a regular fruit flavoured powder that has no benefits). Participants will be randomly allocated to a group and will not be told which supplement they are taking until the end of the trial. The supplement will be taken as a drink 4 times a day for the first 5 days, and then once a day for the remainder of the 12 weeks.
Participants will be asked to attend Bangor University 4 times to have a series of tests done.
The four testing points are:
before they start supplementation
after the 5 days
at completion of the 12-weeks of supplementation
12 weeks after completion of the 12 week supplementation period.
At all four testing points (1-4) body fat and muscle size (body composition), physical function, and fitness (aerobic capacity of the heart and lungs to transport oxygen to the exercising muscles) will be tested. In addition, quality of life questionnaires will be completed, disease activity will be assessed and blood samples will be taken. Muscle samples (muscle biopsy) will be obtained, from those who volunteer to provide them, at baseline and post-treatment (test points 1 and 3).
Body fat and muscle size (body composition) will be assessed using type of X-ray called 'dual-entry X-ray absorptiometry' (DXA) scans and by looking at body water levels. DXA allows the research team to estimate the amount of lean tissue (muscle) and fat that is in the body. The scan is completely painless.
Physical function will be assessed using the following tests:
strength tests of the knee muscles and hand-grip
the Up-and-Go Test (UG) - For the UG, participants are required rise from a seated position on a fixed chair, walk forward to a cone placed 8ft (2.44 m) away, and return to the chair and a seated position.
the sit-to-stand in 30 sec test (SST-30) - For the SST-30 participants will rise from the same seated position as during the UG as many times as possible in 30 s whilst keeping their arms folded across the chest.
50-ft walk test - During the 50-ft walk test, time taken to complete the walk along a straight line marked by cones is recorded
To assess fitness participants will complete a step test. During the test participants are required to step up and down a 10-inch step at a tempo controlled by a metronome for three x three-minute stages or until the target heart rate (65% of predicted maximum heart rate) is achieved. This test will normally last 3 minutes
What are the potential risks and benefits?
Risks - A disadvantage of taking part is the time commitment required to participate in the study. Whilst taking the supplement drink will be quick and simple, there are 4 testing sessions which may 2 hours in which participants must attend at Bangor University. Any travel expenses participants incur for participating in this study will be paid for.
Creatine supplementation will cause some weight gain; in the short-term this is due to water retention by the muscle and in the long-term this is due to an increase in muscle size. Previous research, including research with RA patients, has found no adverse side effects that can be linked to the creatine supplementation. There are anecdotal reports of creatine supplementation causing muscle cramps, stomach and heart problems; however no evidence has ever linked these directly to the creatine itself.
There is also a slight possibility that the muscle biopsy site (where the muscle is taken) could bruise and be sore but this is quite rare and in fact most people report only a short term slight ache after the biopsy.
There is also an exposure to radiation (emission of energy) from the DXA scan, though this is only a small amount. However, because of this radiation pregnant women are not allowed to part in the study.
Benefits - Taking creatine supplements will increase muscle strength and improve physical function and quality of life.
Participants will receive creatine supplementation regardless of which group they are initially put into. Participants will also be informed about their fitness levels and will receive advice on how to improve these.
The standard DXA can inform the investigaters of a disease in the bone that can increase the risk of fractures (osteoporosis) that patients might not know they had.
Who is running the study and how long will it last? The study will commence in January 2012 and is being undertaken by the School of Sport, Health and Exericse Sciences (SSHES) at Bangor University, Wales, in association with the Rheumatology department at Ysbyty Gwynedd Hospital, Bangor.
Who is funding the study? The study is being funded by Betsi Cadwalader University Health Board. The study is expected to finish within an 18 month time frame, with recruiting open for a year or until 50 patients have been found.
Who is the main contact? Prof Andrew Lemmey a.lemmey@bangor.ac.uk Dr Tom O'Brien thomas.obrien@bangor.ac.uk Thomas Wilkinson, thomas.wilkinson@bangor.ac.uk
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Rheumatoid Arthritis
Keywords
Rheumatoid Arthritis, Arthritis, Rheumatology, Creatine
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
43 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Creatine
Arm Type
Experimental
Arm Description
Creatine, often found in meat and fish, make up an essential part of the systems that provide energy to the muscles for movement and exercise.
Arm Title
Fruit powder drink
Arm Type
Placebo Comparator
Arm Description
A regular fruit flavoured powder that has no benefits
Intervention Type
Dietary Supplement
Intervention Name(s)
Creatine
Other Intervention Name(s)
Creatine Monohydrate (MyProtein.uk), SN: 5055534301999 BB: 09/2014
Intervention Description
Creatine, often found in meat and fish, make up an essential part of the systems that provide energy to the muscles for movement and exercise.
Intervention Type
Dietary Supplement
Intervention Name(s)
Placebo
Other Intervention Name(s)
Placebo Comparator: Fruit powder drink - A regular fruit flavoured powder that has no benefits., Manufactured by Foster Clarks Ltd (www.fosterclark.com)
Primary Outcome Measure Information:
Title
Change in 'Objectively assessed whole body function'
Description
Physical function will be assessed using the following tests:
strength tests of the knee muscles and hand-grip
the Up-and-Go Test (UG) - For the UG, participants are required rise from a seated position on a fixed chair, walk forward to a cone placed 8ft (2.44 m) away, and return to the chair and a seated position.
the sit-to-stand in 30 sec test (SST-30) - For the SST-30 participants will rise from the same seated position as during the UG as many times as possible in 30 s whilst keeping their arms folded across the chest.
50-ft walk test - During the 50-ft walk test, time taken to complete the walk along a straight line marked by cones is recorded
To assess fitness participants will complete the Siconolfi step test.
Time Frame
Measured at Baseline, Day 6, Week 12, Week 24
Secondary Outcome Measure Information:
Title
Change in body composition
Description
Body fat and muscle size (body composition) will be assessed using type of X-ray called 'dual-entry X-ray absorptiometry' (DXA) scans and by looking at body water levels. DXA allows the research team to estimate the amount of lean tissue (muscle) and fat that is in the body. The scan is completely painless.
Time Frame
Baseline, Day 6, Week 12, Week 24
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
fulfil the American Rheumatism Association 1987 revised criteria for the diagnosis of RA
be functional class I or II
be age 18 years or over
Exclusion Criteria:
be cognitively impaired; (b) have any other cachectic diseases and any condition preventing safe participation in the study
have a glomerular filtration rate above 60mL/min/1.73m2, assessed from medical records, and no other evidence of kidney damage
be taking drugs or other nutritional supplements known to increase muscle mass
be participating in regular and intense physical training program be pregnant
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Andrew B Lemmey, Prof.
Organizational Affiliation
Bangor University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Thomas O'Brien, Dr
Organizational Affiliation
Bangor University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Thomas J Wilkinson
Organizational Affiliation
Bangor Unversity
Official's Role
Principal Investigator
Facility Information:
Facility Name
Bangor University
City
Bangor
State/Province
Gwynedd
ZIP/Postal Code
LL572PZ
Country
United Kingdom
12. IPD Sharing Statement
Citations:
PubMed Identifier
10788538
Citation
Willer B, Stucki G, Hoppeler H, Bruhlmann P, Krahenbuhl S. Effects of creatine supplementation on muscle weakness in patients with rheumatoid arthritis. Rheumatology (Oxford). 2000 Mar;39(3):293-8. doi: 10.1093/rheumatology/39.3.293.
Results Reference
background
PubMed Identifier
21885521
Citation
Lemmey AB, Jones J, Maddison PJ. Rheumatoid cachexia: what is it and why is it important? J Rheumatol. 2011 Sep;38(9):2074; author reply 2075. doi: 10.3899/jrheum.110308. No abstract available.
Results Reference
background
PubMed Identifier
21671413
Citation
Lemmey AB, Williams SL, Marcora SM, Jones J, Maddison PJ. Are the benefits of a high-intensity progressive resistance training program sustained in rheumatoid arthritis patients? A 3-year followup study. Arthritis Care Res (Hoboken). 2012 Jan;64(1):71-5. doi: 10.1002/acr.20523.
Results Reference
background
PubMed Identifier
19950325
Citation
Lemmey AB, Marcora SM, Chester K, Wilson S, Casanova F, Maddison PJ. Effects of high-intensity resistance training in patients with rheumatoid arthritis: a randomized controlled trial. Arthritis Rheum. 2009 Dec 15;61(12):1726-34. doi: 10.1002/art.24891.
Results Reference
background
PubMed Identifier
15896432
Citation
Marcora S, Lemmey A, Maddison P. Dietary treatment of rheumatoid cachexia with beta-hydroxy-beta-methylbutyrate, glutamine and arginine: a randomised controlled trial. Clin Nutr. 2005 Jun;24(3):442-54. doi: 10.1016/j.clnu.2005.01.006. Epub 2005 Apr 21.
Results Reference
background
PubMed Identifier
21403833
Citation
Cooney JK, Law RJ, Matschke V, Lemmey AB, Moore JP, Ahmad Y, Jones JG, Maddison P, Thom JM. Benefits of exercise in rheumatoid arthritis. J Aging Res. 2011 Feb 13;2011:681640. doi: 10.4061/2011/681640.
Results Reference
background
PubMed Identifier
12433852
Citation
Nissen SL, Sharp RL. Effect of dietary supplements on lean mass and strength gains with resistance exercise: a meta-analysis. J Appl Physiol (1985). 2003 Feb;94(2):651-9. doi: 10.1152/japplphysiol.00755.2002. Epub 2002 Oct 25.
Results Reference
background
Learn more about this trial
Can Creatine Supplementation Improve Body Composition and Physical Function in Rheumatoid Arthritis Patients?
We'll reach out to this number within 24 hrs